Page 5,814«..1020..5,8135,8145,8155,816..5,8205,830..»

UTAS Pharmacy – the fast track to pharmacy – Video

Posted: Published on January 25th, 2013

UTAS Pharmacy - the fast track to pharmacy The UTAS School of Pharmacy offers a Fast Track course for students who have previously studied science or health-science. Eligible students complete this four week summer course, and go straight into 2nd year of the BPharm degree. Why choose fast track? Here's why... By: SchoolofPharmacyUTAS … Continue reading

Posted in Pharmacy | Comments Off on UTAS Pharmacy – the fast track to pharmacy – Video

Avella Specialty Pharmacy | ACE Award CEO John Musil – Video

Posted: Published on January 25th, 2013

Avella Specialty Pharmacy | ACE Award CEO John Musil Avella Specialty Pharmacy formally known as The Apothecary Shops is presented with the ACE Award. In this short video Avella CEO John Musil describes By: avellaRx … Continue reading

Posted in Pharmacy | Comments Off on Avella Specialty Pharmacy | ACE Award CEO John Musil – Video

Trio facing charges in November break-in at Saline pharmacy

Posted: Published on January 25th, 2013

Three people are accused of breaking into a Saline pharmacy in November and stealing prescription pills, according to court records. A 21-year-old man, a 33-year-old man and a 40-year-old woman are facing charges of breaking and entering a building with intent to commit a crime, according to warrants filed at the Washtenaw County Trial Court. The three are accused of breaking into Jensens Community Pharmacy, 968 E. Michigan Ave., early on Nov. 17. Jensen's Community Pharmacy is at 968 E. Michigan Ave. in Saline. photo via http://www.jensenscommunitypharmacy.com The report stated there was a shoe print and smudged fingerprints left in the store. Stolen pills included medication for urinary problems, headaches and anxiety. The intruders did not touch cash or Schedule II narcotics in the store. The day after the break-in, police reviewed security tape from a nearby Ace Hardware store. The video showed a dark Jeep Liberty driving toward the pharmacy just before police were dispatched by the alarm. Police in Monroe later arrested four people involved in a pharmacy burglary who also were driving a dark Jeep Liberty and notified Saline investigators. According to the report, the four suspects admitted their involvement in the Jensens Pharmacy break-in. Saline police … Continue reading

Posted in Pharmacy | Comments Off on Trio facing charges in November break-in at Saline pharmacy

Pharmacy blamed for outbreak paid $70 million to insiders

Posted: Published on January 25th, 2013

Posted: 7:42 PM Updated: 8:32 PM The Associated Press SPRINGFIELD, Mass. An attorney for creditors of a pharmacy blamed for a nationwide meningitis outbreak said Thursday that the firm paid out $70 million to company insiders over the last six years. Attorney David Molton made the disclosure at a U.S. Bankruptcy Court hearing in Springfield as he argued that creditors should be allowed to seek to freeze the assets of the New England Compounding Center's owners. Molton said the company had paid its four owners, or companies they owned, $37 million over the last two years, $68 million over the last four years and $70.5 million over the last six years. He argued the company's history of big payouts indicated there was a "grave, grave, grave risk" that what remained of those payments would be further depleted before creditors get paid. "When money came in, it went out," Molton said. Judge Henry Boroff granted the motion and scheduled a hearing Friday on arguments about tying up the defendants' assets. A tainted steroid produced by the Framingham-based compounding pharmacy has been linked to a fungal meningitis outbreak that's killed 44 people and sickened more than 600. The outbreak was discovered in … Continue reading

Posted in Pharmacy | Comments Off on Pharmacy blamed for outbreak paid $70 million to insiders

The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs

Posted: Published on January 25th, 2013

PHOENIX, Jan. 24, 2013 /PRNewswire/ -- The Arizona Chapter of The Leukemia & Lymphoma Society and Avella Specialty Pharmacyannounce theywill present a day of discussion about the latest advancements, trends and management of oral chemotherapy medications. The free event will take place on Feb. 9, from 10:30 a.m. to 2:30 p.m., at SkySong, the ASU Scottsdale Innovation Center, 1475 N. Scottsdale Road, Scottsdale. Local hematology/oncology community members will provide in-depth presentations on oral chemotherapy drugs including current trends, compliance and medication management. The event will feature two breakout sessions one for nurses wherein they can earn complimentary CE credits and the other track for cancer patients and their families as well as a town hall-style session featuring several local experts. "More than 35 percent of the 400 cancer drugs in the pipeline are oral chemotherapy drugs. They clearly are the wave of the future," stated John Musil, Pharm.D., founder and CEO of Avella. "However, with so many breakthroughs, it's difficult for patients to stay on top of all of them. Our partnership with The Leukemia & Lymphoma Society aligns with our mission of optimizing patient health by educating healthcare professionals and patients on these advancements. Our hope is to provide … Continue reading

Posted in Pharmacy | Comments Off on The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs

Pharmacy owner nabbed for illegally selling Nubain

Posted: Published on January 25th, 2013

Cebu Daily News A pharmacy owner allegedly involved in the illegal sale of Nubain, a regulated painkiller, was arrested in a buy-bust operation yesterday afternoon. Napoleon Ricamora, a registered nurse and owner of Nars Paharmacy, was arrested after a brief chase with police. Also arrested was Ricamoras alleged cohort, Calvin Klein Caete. Police said the suspects met an agent of the Philippine Drug Enforcement Agency in Central Visayas (PDEA-7) who acted as a poseur-buyer during the operation in barangay Capitol Site, Cebu City. The transaction took place near a hospital. Police said it was Caete who approached the poseur-buyer while Ricamora stayed in a Toyota Fortuner SUV. Caete allegedly handed over 30 ampules of Nubain worth P9,600 to the PDEA agent. Ricamora then got off the SUV and joined in the transaction. PDEA operatives moved in when the poseur-buyer handed over the P5,000 marked money to the suspects. PDEA agents cornered Caete but Ricamora was able to run to his car and drove off. Go here to see the original: Pharmacy owner nabbed for illegally selling Nubain … Continue reading

Posted in Pharmacy | Comments Off on Pharmacy owner nabbed for illegally selling Nubain

Pharmacy attracts students from far far away

Posted: Published on January 25th, 2013

(L-R) Carrissa James and Alana Purcell were among the 22 students who attended the camp. Aboriginal and Torres Strait Islander students from as far as away as Humpty Doo in the Northern Territory attended the inaugural University of Sydney Pharmacy Indigenous Camp held this week. Carissa James from Lismore in northern NSW, and Alana Purcell from Cairns in Queensland, were among 22 high school students who attended the four-day Pharmacy Indigenous Camp (SydPIC). SydPic was aimed at boosting the numbers of Aboriginal and Torres Strait Islanders currently employed in the pharmacy profession. With fewer than 50 registered pharmacists in Australia who identify as Aboriginal or Torres Strait Islander, course coordinators Drs Nial Wheate and Rebekah Moles believe it is imperative more Aboriginal pharmacists be trained, particularly in regions where Aboriginal communities are lacking health professionals. Dr Nial Wheate believes the shortage of Aboriginal and Torres Strait Islander pharmacists has been a result of lack of engagement with high school students about career options in pharmacy. "We developed the camp to bring together interested students from all around Australia to get a taste of what it's like to be a pharmacist and experience university life first-hand. "During the camp the students … Continue reading

Posted in Pharmacy | Comments Off on Pharmacy attracts students from far far away

Seattle Genetics and Millennium Initiate Global Phase III Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Front …

Posted: Published on January 24th, 2013

BOTHELL, Wash. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas. The trial, also known as ECHELON-2, is being conducted under a Special Protocol Assessment (SPA) agreement from the U.S. Food and Drug Administration (FDA) and also received scientific advice from the European Medicines Agency (EMA). ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30. ADCETRIS is currently not approved for use in the front-line treatment of MTCL. The standard of care for newly diagnosed MTCL, a chemotherapy regimen called CHOP, has not changed in more than three decades, and there is a significant need to identify enhanced treatment options for these patients, said Clay B. Siegall, Ph.D., President and Chief Executive Officer at Seattle Genetics. Recent phase I data from 26 patients presented at the ASH annual meeting showed that adding ADCETRIS to CHP resulted in compelling … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Seattle Genetics and Millennium Initiate Global Phase III Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Front …

BrainStorm’s CEO Issues Annual Letter to Shareholders

Posted: Published on January 24th, 2013

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)-- BrainStorm Cell Therapeutics (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that its CEO, Dr. Adrian Harel, has issued an Annual Letter to Shareholders summarizing the companys extremely significant developments of 2012: Dear BrainStorm Shareholders, 2012 has been a pivotal year for BrainStorm, as the company has achieved the most significant milestones since its inception. Weve made dramatic progress in our clinical trials, establishing the safety of NurOwn cells in a first group of ALS patients and demonstrating promising indications of clinical improvement in some patients. As a result weve been fast-tracked to a Phase IIa preliminary efficacy trial after only one year of testing. Weve also made key advances in product development, and secured the largest amount of financing in any single year of operations. I am proud to share with you the major highlights of the past twelve months: I. Clinical Trials Progress In early June, we performed the 12th ALS patient transplantation in our Phase I/II clinical trial with NurOwn at Hadassah Medical Center in Jerusalem. In July, we submitted a positive interim safety report to the Israeli Ministry of Health (MOH) on the … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on BrainStorm’s CEO Issues Annual Letter to Shareholders

Clinical trial seeks patients with critical limb ischemia

Posted: Published on January 24th, 2013

Doctors hope clinical trials using a new stem cell therapy will help patients with critical limb ischemia lead better lives. The Phase 3 trial, called REVIVE, is taking place around the country, including locally through the Michigan CardioVascular Institute. Critical limb ischemia is a form of peripheral arterial disease that occurs when arteries supplying blood to the legs become blocked. This can cause pain or numbness in the feet, open sores or ulcers and eventually gangrene of the legs or feet. The condition affects about 1 to 1.5 million Americans overall. A good number of them can be helped with procedures to bypass the arteries, but about 25 to 30 percent of patients cannot have that kind of treatment, according to Dr. Safwan Kassas, director of the Cardiovascular Cell Therapy and Regenerative Medicine Program at Michigan CardioVascular Institute. Out of this 25-30 percent, today, there is no treatment, he said. The FDA has not approved any treatment for them. Theyre really in a very dismal spot. Statistics show within first year of developing critical limb ischemia, 25 percent of people will die, 25 percent will have amputation and 50 percent will be alive without amputation, Kassas said. He said in … Continue reading

Comments Off on Clinical trial seeks patients with critical limb ischemia

Page 5,814«..1020..5,8135,8145,8155,816..5,8205,830..»